Hirokazu Hashishita
Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Association of immune-related adverse events with survival in patients receiving immune checkpoint inhibitor plus chemotherapy for lung cancer.
Journal: Scientific reports
Published: March 25, 2025
Pharmacist Intervention in Outpatients With Prostate Cancer Prevents Apalutamide-induced Skin Adverse Events.
Journal: In vivo (Athens, Greece)
Published: October 15, 2024
Risk Factors for Eribulin-induced Severe Neutropenia in Patients With Recurrent Breast Cancer.
Journal: In vivo (Athens, Greece)
Published: September 27, 2023
Clinical Management of Potential Toxicity of Abemaciclib and Approaches to Ensure Treatment Continuation.
Journal: Asian Pacific journal of cancer prevention : APJCP
Published: January 13, 2023
Identifying Early Predictive Markers for Immune-Related Adverse Events in Nivolumab-Treated Patients with Renal Cell Carcinoma and Gastric Cancer.
Journal: Asian Pacific journal of cancer prevention : APJCP
Published: October 04, 2021
Factors Contributing to the Occurrence of Edema in Breast Cancer Patients Receiving DTX Treatment
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: July 17, 2020
Axitinib-Induced Hypothyroidism as a Predictor of Long-Term Survival in Patients with Metastatic Renal Cell Carcinoma.
Journal: Urologia internationalis
Published: January 08, 2019
Skin Disorders and Primary Tumor Location as Prognostic Factors in Patients with Metastatic Colorectal Cancer Treated with Cetuximab and Chemotherapy
Journal: Asian Pacific journal of cancer prevention : APJCP
Published: August 25, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026